Share Price and Basic Stock Data
Last Updated: December 12, 2025, 7:10 am
| PEG Ratio | 0.45 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Narmada Agrobase Ltd operates within the animal and shrimp feed industry, a sector that has been gaining traction as global protein demand increases. The company’s recent revenue trajectory reflects this growing demand. For the fiscal year ending March 2025, Narmada reported sales of ₹64.68 Cr, a significant increase from ₹49.48 Cr in the previous fiscal year. This upward trend is particularly pronounced in the quarter ending March 2025, where sales rose to ₹29.30 Cr, showcasing a robust growth pattern. However, the company did face fluctuations throughout the fiscal year, with quarterly sales dipping to ₹7.91 Cr in June 2022 before rebounding. Such volatility may indicate seasonal impacts or operational challenges but also highlights the potential for rebound during peak demand periods.
Profitability and Efficiency Metrics
Profitability metrics for Narmada Agrobase Ltd show a mixed bag of performance. The operating profit margin (OPM) has seen a notable rise, reaching 11.91% in the latest quarter, a significant improvement compared to the margins reported in earlier quarters. This is a positive sign, suggesting that the company is managing its operational costs effectively. However, the net profit margin of 6.22% for the fiscal year ending March 2025, despite being an improvement from previous years, still indicates that there are constraints affecting overall profitability. The return on equity (ROE) stands at 11.2%, which appears reasonable but may not be sufficiently attractive when compared to higher benchmarks in the industry. Additionally, the cash conversion cycle has stretched to 260.66 days, reflecting potential inefficiencies in inventory management and receivables collection that could hinder cash flow.
Balance Sheet Strength and Financial Ratios
Narmada Agrobase’s balance sheet reflects a cautious yet growing financial posture. The total borrowings reported at ₹10.53 Cr against reserves of ₹19.98 Cr present a leverage ratio that seems manageable, suggesting a prudent approach to financing. The interest coverage ratio of 7.44x indicates that the company comfortably meets its interest obligations, which is a reassuring factor for investors. Furthermore, the current ratio is a strong 6.21, signaling ample liquidity to cover short-term liabilities. However, the price-to-book value ratio stands at 1.11x, which, while not alarming, suggests that the stock may not be undervalued compared to its net asset value. Investors should also note the increasing trend in total liabilities, which rose to ₹66.46 Cr in March 2025, as this could impact future financial flexibility.
Shareholding Pattern and Investor Confidence
The shareholding structure of Narmada Agrobase Ltd reveals a significant shift in ownership dynamics, particularly regarding promoter stakes. As of June 2025, promoters hold 50.30% of the shares, down from 66.47% in December 2022. This decline may raise questions about confidence among the founders, particularly if the trend continues. On the other hand, the presence of domestic institutional investors (DIIs) has increased to 8.96%, indicating growing institutional interest and confidence in the company’s potential. The public holding remains substantial at 40.74%, reflecting a broad base of retail investors. The increase in the number of shareholders from 881 in December 2022 to 11,308 by June 2025 suggests that the company is attracting attention and interest, which could bode well for liquidity and market sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Narmada Agrobase Ltd presents a mixed outlook. While the company has demonstrated strong revenue growth and improving profitability metrics, several risks loom. The high cash conversion cycle poses a significant challenge, potentially impacting liquidity and operational efficiency. Additionally, the declining promoter stake might raise concerns about long-term commitment to the company’s growth. On the upside, increasing institutional investment could provide more stability and support for the stock. Investors should weigh these factors carefully; the company’s growth potential in the animal feed sector is promising, but operational and governance risks could temper future performance. Thus, a watchful approach is warranted, balancing optimism about growth against the backdrop of emerging challenges.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Narmada Agrobase Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Narmada Agrobase Ltd | 80.5 Cr. | 21.2 | 28.4/14.6 | 21.0 | 15.3 | 0.00 % | 13.0 % | 11.2 % | 10.0 |
| Godrej Agrovet Ltd | 11,379 Cr. | 592 | 876/560 | 26.1 | 94.1 | 1.86 % | 16.6 % | 17.7 % | 10.0 |
| Avanti Feeds Ltd | 10,977 Cr. | 806 | 965/572 | 17.8 | 221 | 1.12 % | 24.0 % | 19.5 % | 1.00 |
| Ajooni Biotech Ltd | 77.7 Cr. | 4.51 | 8.55/4.16 | 19.5 | 5.21 | 0.00 % | 6.91 % | 5.15 % | 2.00 |
| Industry Average | 11,178.00 Cr | 355.93 | 21.10 | 83.90 | 0.75% | 15.13% | 13.39% | 5.75 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.91 | 13.24 | 10.62 | 18.26 | 7.95 | 11.41 | 12.22 | 18.75 | 12.26 | 10.28 | 13.84 | 29.30 | 11.08 |
| Expenses | 7.52 | 12.61 | 10.06 | 17.81 | 7.50 | 10.94 | 11.77 | 17.60 | 10.68 | 8.21 | 12.50 | 28.71 | 9.76 |
| Operating Profit | 0.39 | 0.63 | 0.56 | 0.45 | 0.45 | 0.47 | 0.45 | 1.15 | 1.58 | 2.07 | 1.34 | 0.59 | 1.32 |
| OPM % | 4.93% | 4.76% | 5.27% | 2.46% | 5.66% | 4.12% | 3.68% | 6.13% | 12.89% | 20.14% | 9.68% | 2.01% | 11.91% |
| Other Income | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 | 0.00 | 0.01 | 0.01 | 0.32 | 0.32 | 0.33 |
| Interest | 0.20 | 0.19 | 0.22 | 0.25 | 0.23 | 0.23 | 0.23 | 0.26 | 0.24 | 0.24 | 0.21 | 0.16 | 0.24 |
| Depreciation | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 |
| Profit before tax | 0.12 | 0.37 | 0.27 | 0.13 | 0.16 | 0.20 | 0.17 | 0.82 | 1.29 | 1.78 | 1.39 | 0.69 | 1.36 |
| Tax % | 33.33% | 27.03% | 25.93% | 23.08% | 31.25% | 15.00% | 23.53% | 25.61% | 21.71% | 26.97% | 28.06% | -13.04% | 25.00% |
| Net Profit | 0.08 | 0.27 | 0.20 | 0.10 | 0.11 | 0.17 | 0.13 | 0.61 | 1.02 | 1.29 | 1.00 | 0.78 | 1.02 |
| EPS in Rs | 0.02 | 0.07 | 0.05 | 0.03 | 0.03 | 0.04 | 0.03 | 0.16 | 0.27 | 0.34 | 0.26 | 0.21 | 0.27 |
Last Updated: August 20, 2025, 6:25 am
Below is a detailed analysis of the quarterly data for Narmada Agrobase Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 11.08 Cr.. The value appears to be declining and may need further review. It has decreased from 29.30 Cr. (Mar 2025) to 11.08 Cr., marking a decrease of 18.22 Cr..
- For Expenses, as of Jun 2025, the value is 9.76 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 28.71 Cr. (Mar 2025) to 9.76 Cr., marking a decrease of 18.95 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.32 Cr.. The value appears strong and on an upward trend. It has increased from 0.59 Cr. (Mar 2025) to 1.32 Cr., marking an increase of 0.73 Cr..
- For OPM %, as of Jun 2025, the value is 11.91%. The value appears strong and on an upward trend. It has increased from 2.01% (Mar 2025) to 11.91%, marking an increase of 9.90%.
- For Other Income, as of Jun 2025, the value is 0.33 Cr.. The value appears strong and on an upward trend. It has increased from 0.32 Cr. (Mar 2025) to 0.33 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Jun 2025, the value is 0.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.16 Cr. (Mar 2025) to 0.24 Cr., marking an increase of 0.08 Cr..
- For Depreciation, as of Jun 2025, the value is 0.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.06 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.36 Cr.. The value appears strong and on an upward trend. It has increased from 0.69 Cr. (Mar 2025) to 1.36 Cr., marking an increase of 0.67 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from -13.04% (Mar 2025) to 25.00%, marking an increase of 38.04%.
- For Net Profit, as of Jun 2025, the value is 1.02 Cr.. The value appears strong and on an upward trend. It has increased from 0.78 Cr. (Mar 2025) to 1.02 Cr., marking an increase of 0.24 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.27. The value appears strong and on an upward trend. It has increased from 0.21 (Mar 2025) to 0.27, marking an increase of 0.06.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:47 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.97 | 30.53 | 34.45 | 37.00 | 47.50 | 61.46 | 58.14 | 34.61 | 49.48 | 49.74 | 64.68 | 64.50 |
| Expenses | 21.12 | 29.35 | 33.02 | 35.43 | 45.87 | 59.00 | 55.90 | 32.61 | 47.46 | 47.22 | 59.10 | 59.18 |
| Operating Profit | 0.85 | 1.18 | 1.43 | 1.57 | 1.63 | 2.46 | 2.24 | 2.00 | 2.02 | 2.52 | 5.58 | 5.32 |
| OPM % | 3.87% | 3.87% | 4.15% | 4.24% | 3.43% | 4.00% | 3.85% | 5.78% | 4.08% | 5.07% | 8.63% | 8.25% |
| Other Income | 0.02 | 0.02 | 0.02 | 0.07 | 0.28 | 0.03 | 0.04 | 0.06 | 0.05 | 0.07 | 0.66 | 0.98 |
| Interest | 0.43 | 0.70 | 0.75 | 0.82 | 0.70 | 1.03 | 0.85 | 0.82 | 0.86 | 0.96 | 0.84 | 0.85 |
| Depreciation | 0.27 | 0.27 | 0.30 | 0.28 | 0.54 | 0.40 | 0.42 | 0.37 | 0.32 | 0.28 | 0.24 | 0.23 |
| Profit before tax | 0.17 | 0.23 | 0.40 | 0.54 | 0.67 | 1.06 | 1.01 | 0.87 | 0.89 | 1.35 | 5.16 | 5.22 |
| Tax % | 17.65% | 21.74% | 25.00% | 25.93% | 25.37% | 25.47% | 32.67% | 31.03% | 26.97% | 24.44% | 20.74% | |
| Net Profit | 0.14 | 0.19 | 0.30 | 0.40 | 0.50 | 0.79 | 0.68 | 0.61 | 0.65 | 1.02 | 4.09 | 4.09 |
| EPS in Rs | 0.22 | 0.21 | 0.33 | 0.15 | 0.13 | 0.21 | 0.18 | 0.16 | 0.17 | 0.27 | 1.08 | 1.08 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 15.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 35.71% | 57.89% | 33.33% | 25.00% | 58.00% | -13.92% | -10.29% | 6.56% | 56.92% | 300.98% |
| Change in YoY Net Profit Growth (%) | 0.00% | 22.18% | -24.56% | -8.33% | 33.00% | -71.92% | 3.63% | 16.85% | 50.37% | 244.06% |
Narmada Agrobase Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 1% |
| 3 Years: | 24% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 39% |
| 3 Years: | 89% |
| TTM: | 112% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 10% |
| 1 Year: | 31% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 7% |
| 3 Years: | 8% |
| Last Year: | 11% |
Last Updated: September 5, 2025, 11:30 am
Balance Sheet
Last Updated: December 4, 2025, 1:42 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.25 | 1.83 | 1.83 | 5.19 | 7.53 | 13.55 | 13.55 | 13.55 | 13.55 | 13.55 | 37.94 | 37.94 |
| Reserves | 0.11 | 0.30 | 0.64 | 0.42 | 6.04 | 0.71 | 1.39 | 1.68 | 2.33 | 3.35 | 17.93 | 19.98 |
| Borrowings | 6.71 | 7.93 | 10.22 | 7.39 | 9.13 | 8.44 | 8.69 | 9.72 | 10.07 | 9.68 | 9.47 | 10.53 |
| Other Liabilities | 0.89 | 0.67 | 0.98 | 1.44 | 0.88 | 1.57 | 3.29 | 1.55 | 1.37 | 1.38 | 1.12 | 2.27 |
| Total Liabilities | 8.96 | 10.73 | 13.67 | 14.44 | 23.58 | 24.27 | 26.92 | 26.50 | 27.32 | 27.96 | 66.46 | 70.72 |
| Fixed Assets | 2.38 | 2.71 | 2.66 | 2.74 | 4.66 | 3.89 | 3.50 | 3.75 | 3.44 | 3.18 | 2.97 | 2.98 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| Investments | 0.21 | 0.21 | 0.43 | 0.47 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 |
| Other Assets | 6.37 | 7.81 | 10.58 | 11.23 | 18.31 | 20.38 | 23.42 | 22.75 | 23.88 | 24.78 | 63.47 | 67.49 |
| Total Assets | 8.96 | 10.73 | 13.67 | 14.44 | 23.58 | 24.27 | 26.92 | 26.50 | 27.32 | 27.96 | 66.46 | 70.72 |
Below is a detailed analysis of the balance sheet data for Narmada Agrobase Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 37.94 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 37.94 Cr..
- For Reserves, as of Sep 2025, the value is 19.98 Cr.. The value appears strong and on an upward trend. It has increased from 17.93 Cr. (Mar 2025) to 19.98 Cr., marking an increase of 2.05 Cr..
- For Borrowings, as of Sep 2025, the value is 10.53 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 9.47 Cr. (Mar 2025) to 10.53 Cr., marking an increase of 1.06 Cr..
- For Other Liabilities, as of Sep 2025, the value is 2.27 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.12 Cr. (Mar 2025) to 2.27 Cr., marking an increase of 1.15 Cr..
- For Total Liabilities, as of Sep 2025, the value is 70.72 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 66.46 Cr. (Mar 2025) to 70.72 Cr., marking an increase of 4.26 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2.98 Cr.. The value appears strong and on an upward trend. It has increased from 2.97 Cr. (Mar 2025) to 2.98 Cr., marking an increase of 0.01 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.02 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
- For Investments, as of Sep 2025, the value is 0.25 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 0.25 Cr., marking an increase of 0.25 Cr..
- For Other Assets, as of Sep 2025, the value is 67.49 Cr.. The value appears strong and on an upward trend. It has increased from 63.47 Cr. (Mar 2025) to 67.49 Cr., marking an increase of 4.02 Cr..
- For Total Assets, as of Sep 2025, the value is 70.72 Cr.. The value appears strong and on an upward trend. It has increased from 66.46 Cr. (Mar 2025) to 70.72 Cr., marking an increase of 4.26 Cr..
Notably, the Reserves (19.98 Cr.) exceed the Borrowings (10.53 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.86 | -6.75 | -8.79 | -5.82 | -7.50 | -5.98 | -6.45 | -7.72 | -8.05 | -7.16 | -3.89 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 30.07 | 26.66 | 31.89 | 31.07 | 58.02 | 67.41 | 101.83 | 151.97 | 97.52 | 97.74 | 107.56 |
| Inventory Days | 73.60 | 54.43 | 70.88 | 75.62 | 70.33 | 37.81 | 28.83 | 77.66 | 75.95 | 84.67 | 154.49 |
| Days Payable | 10.54 | 6.97 | 8.63 | 11.98 | 3.54 | 4.02 | 15.92 | 10.03 | 7.25 | 6.35 | 1.38 |
| Cash Conversion Cycle | 93.13 | 74.11 | 94.14 | 94.71 | 124.80 | 101.19 | 114.74 | 219.59 | 166.22 | 176.06 | 260.66 |
| Working Capital Days | 21.27 | 25.70 | 26.81 | 25.35 | 59.01 | 53.09 | 64.10 | 104.62 | 87.34 | 94.00 | 194.58 |
| ROCE % | 10.26% | 10.11% | 10.59% | 7.68% | 9.21% | 8.20% | 6.96% | 6.88% | 8.79% | 13.05% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.56 | 0.75 | 0.48 | 0.41 | 0.56 |
| Diluted EPS (Rs.) | 1.56 | 0.75 | 0.48 | 0.41 | 0.56 |
| Cash EPS (Rs.) | 1.14 | 0.95 | 0.71 | 0.67 | 0.86 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.73 | 12.47 | 11.72 | 11.43 | 11.03 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.73 | 12.47 | 11.72 | 11.43 | 11.03 |
| Revenue From Operations / Share (Rs.) | 17.31 | 37.14 | 36.92 | 25.81 | 43.00 |
| PBDIT / Share (Rs.) | 1.64 | 1.91 | 1.53 | 1.46 | 1.68 |
| PBIT / Share (Rs.) | 1.58 | 1.71 | 1.29 | 1.19 | 1.37 |
| PBT / Share (Rs.) | 1.36 | 0.99 | 0.65 | 0.58 | 0.74 |
| Net Profit / Share (Rs.) | 1.08 | 0.75 | 0.48 | 0.40 | 0.55 |
| PBDIT Margin (%) | 9.49 | 5.14 | 4.13 | 5.64 | 3.91 |
| PBIT Margin (%) | 9.12 | 4.59 | 3.50 | 4.59 | 3.19 |
| PBT Margin (%) | 7.85 | 2.68 | 1.77 | 2.27 | 1.73 |
| Net Profit Margin (%) | 6.22 | 2.02 | 1.30 | 1.57 | 1.29 |
| Return on Networth / Equity (%) | 7.31 | 6.03 | 4.10 | 3.55 | 5.04 |
| Return on Capital Employeed (%) | 10.51 | 13.60 | 10.65 | 10.29 | 11.67 |
| Return On Assets (%) | 6.15 | 3.64 | 2.38 | 2.04 | 2.80 |
| Long Term Debt / Equity (X) | 0.02 | 0.01 | 0.03 | 0.00 | 0.05 |
| Total Debt / Equity (X) | 0.16 | 0.57 | 0.63 | 0.62 | 0.53 |
| Asset Turnover Ratio (%) | 1.39 | 1.82 | 1.85 | 1.30 | 2.29 |
| Current Ratio (X) | 6.21 | 2.24 | 2.14 | 1.97 | 1.96 |
| Quick Ratio (X) | 3.73 | 1.33 | 1.31 | 1.41 | 1.59 |
| Inventory Turnover Ratio (X) | 3.25 | 4.58 | 5.67 | 5.72 | 10.22 |
| Interest Coverage Ratio (X) | 7.44 | 2.70 | 2.40 | 2.43 | 2.67 |
| Interest Coverage Ratio (Post Tax) (X) | 5.88 | 2.06 | 1.76 | 1.68 | 1.88 |
| Enterprise Value (Cr.) | 56.46 | 36.45 | 40.59 | 36.04 | 21.25 |
| EV / Net Operating Revenue (X) | 0.85 | 0.72 | 0.81 | 1.03 | 0.36 |
| EV / EBITDA (X) | 9.05 | 14.08 | 19.62 | 18.26 | 9.31 |
| MarketCap / Net Operating Revenue (X) | 0.94 | 0.54 | 0.62 | 0.77 | 0.23 |
| Price / BV (X) | 1.11 | 1.63 | 1.96 | 1.74 | 0.92 |
| Price / Net Operating Revenue (X) | 0.94 | 0.54 | 0.62 | 0.77 | 0.23 |
| EarningsYield | 0.06 | 0.03 | 0.02 | 0.02 | 0.05 |
After reviewing the key financial ratios for Narmada Agrobase Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has increased from 0.75 (Mar 24) to 1.56, marking an increase of 0.81.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has increased from 0.75 (Mar 24) to 1.56, marking an increase of 0.81.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 3. It has increased from 0.95 (Mar 24) to 1.14, marking an increase of 0.19.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.73. It has increased from 12.47 (Mar 24) to 14.73, marking an increase of 2.26.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.73. It has increased from 12.47 (Mar 24) to 14.73, marking an increase of 2.26.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 17.31. It has decreased from 37.14 (Mar 24) to 17.31, marking a decrease of 19.83.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.64. This value is below the healthy minimum of 2. It has decreased from 1.91 (Mar 24) to 1.64, marking a decrease of 0.27.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.58. This value is within the healthy range. It has decreased from 1.71 (Mar 24) to 1.58, marking a decrease of 0.13.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.36. This value is within the healthy range. It has increased from 0.99 (Mar 24) to 1.36, marking an increase of 0.37.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 2. It has increased from 0.75 (Mar 24) to 1.08, marking an increase of 0.33.
- For PBDIT Margin (%), as of Mar 25, the value is 9.49. This value is below the healthy minimum of 10. It has increased from 5.14 (Mar 24) to 9.49, marking an increase of 4.35.
- For PBIT Margin (%), as of Mar 25, the value is 9.12. This value is below the healthy minimum of 10. It has increased from 4.59 (Mar 24) to 9.12, marking an increase of 4.53.
- For PBT Margin (%), as of Mar 25, the value is 7.85. This value is below the healthy minimum of 10. It has increased from 2.68 (Mar 24) to 7.85, marking an increase of 5.17.
- For Net Profit Margin (%), as of Mar 25, the value is 6.22. This value is within the healthy range. It has increased from 2.02 (Mar 24) to 6.22, marking an increase of 4.20.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.31. This value is below the healthy minimum of 15. It has increased from 6.03 (Mar 24) to 7.31, marking an increase of 1.28.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.51. This value is within the healthy range. It has decreased from 13.60 (Mar 24) to 10.51, marking a decrease of 3.09.
- For Return On Assets (%), as of Mar 25, the value is 6.15. This value is within the healthy range. It has increased from 3.64 (Mar 24) to 6.15, marking an increase of 2.51.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.16. This value is within the healthy range. It has decreased from 0.57 (Mar 24) to 0.16, marking a decrease of 0.41.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.39. It has decreased from 1.82 (Mar 24) to 1.39, marking a decrease of 0.43.
- For Current Ratio (X), as of Mar 25, the value is 6.21. This value exceeds the healthy maximum of 3. It has increased from 2.24 (Mar 24) to 6.21, marking an increase of 3.97.
- For Quick Ratio (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 2. It has increased from 1.33 (Mar 24) to 3.73, marking an increase of 2.40.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.25. This value is below the healthy minimum of 4. It has decreased from 4.58 (Mar 24) to 3.25, marking a decrease of 1.33.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.44. This value is within the healthy range. It has increased from 2.70 (Mar 24) to 7.44, marking an increase of 4.74.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.88. This value is within the healthy range. It has increased from 2.06 (Mar 24) to 5.88, marking an increase of 3.82.
- For Enterprise Value (Cr.), as of Mar 25, the value is 56.46. It has increased from 36.45 (Mar 24) to 56.46, marking an increase of 20.01.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.72 (Mar 24) to 0.85, marking an increase of 0.13.
- For EV / EBITDA (X), as of Mar 25, the value is 9.05. This value is within the healthy range. It has decreased from 14.08 (Mar 24) to 9.05, marking a decrease of 5.03.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 24) to 0.94, marking an increase of 0.40.
- For Price / BV (X), as of Mar 25, the value is 1.11. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.11, marking a decrease of 0.52.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 24) to 0.94, marking an increase of 0.40.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.06, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Narmada Agrobase Ltd:
- Net Profit Margin: 6.22%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.51% (Industry Average ROCE: 15.13%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.31% (Industry Average ROE: 13.39%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.88
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.73
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 21 (Industry average Stock P/E: 21.1)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.16
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.22%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Animal/Shrimp Feed | 613/P-1, IJ Pura (Jethaji) Dhanpura Road, Mehsana Gujarat 384421 | infonarmadaagrobase@gmail.com http://www.narmadaagrobase.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Neerajkumar Sureshchandra Agrawal | Managing Director |
| Mr. Suresh Chandra Gupta | Whole Time Director |
| Ms. Pooja Aidasani | Ind. Non-Executive Director |
| Mr. Ganesh Bhavarlal Prajapati | Ind. Non-Executive Director |
| Mr. Deepak Soni | Ind. Non-Executive Director |
| Mr. Shweta Vivek Nathwani | Non Exe. Women Independent Director |
FAQ
What is the intrinsic value of Narmada Agrobase Ltd?
Narmada Agrobase Ltd's intrinsic value (as of 12 December 2025) is 29.36 which is 38.49% higher the current market price of 21.20, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 80.5 Cr. market cap, FY2025-2026 high/low of 28.4/14.6, reserves of ₹19.98 Cr, and liabilities of 70.72 Cr.
What is the Market Cap of Narmada Agrobase Ltd?
The Market Cap of Narmada Agrobase Ltd is 80.5 Cr..
What is the current Stock Price of Narmada Agrobase Ltd as on 12 December 2025?
The current stock price of Narmada Agrobase Ltd as on 12 December 2025 is 21.2.
What is the High / Low of Narmada Agrobase Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Narmada Agrobase Ltd stocks is 28.4/14.6.
What is the Stock P/E of Narmada Agrobase Ltd?
The Stock P/E of Narmada Agrobase Ltd is 21.0.
What is the Book Value of Narmada Agrobase Ltd?
The Book Value of Narmada Agrobase Ltd is 15.3.
What is the Dividend Yield of Narmada Agrobase Ltd?
The Dividend Yield of Narmada Agrobase Ltd is 0.00 %.
What is the ROCE of Narmada Agrobase Ltd?
The ROCE of Narmada Agrobase Ltd is 13.0 %.
What is the ROE of Narmada Agrobase Ltd?
The ROE of Narmada Agrobase Ltd is 11.2 %.
What is the Face Value of Narmada Agrobase Ltd?
The Face Value of Narmada Agrobase Ltd is 10.0.